Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL

NCT03319901 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Venetoclax
DRUG: Standard Chemotherapy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]